Evunzekibart Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5236
Add to Compare
$695.00
Delivery Time : 4 weeks
Add to Wish List
More Information
Concentration 5mg/ml
isotype IgG4 - kappa
Host CHO Cells
Target TNFRSF9
Species Reactivity Human
Specificity Detects human TNFRSF9
Purification Method This monoclonal antibody was purified using Protein A
Formulation Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity >95% by SDS-PAGE
Endotoxin ² 1.0 EU/mg as determined by the LAL method
Storage This biosimilar is stable when stored at 2-8¡C. For longer term storage (> 3 months) it is recommended to store this antibody at -20¡C or -70¡C.
Applications Functional Assays
Application Notes This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time 4 weeks
Write Your Own Review
You're reviewing:Evunzekibart Biosimilar - Research Grade
Your Rating
Who Viewed This Also Viewed
Etokimab Biosimilar - Research Grade
Etokimab Biosimilar - Research Grade
$306.00 - $19,500.00
Human IgG2 Fc plus hinge region
Human IgG2 Fc plus hinge region
$306.00 - $5,100.00
Bulk anti-Human CD19 (4G7) Antibody
Bulk anti-Human CD19 (4G7) Antibody
$390.00 - $2,885.00
Sarilumab Biosimilar - Biotin Research Grade
Sarilumab Biosimilar - Biotin Research Grade
$357.00
Brentuximab Biosimilar - Research Grade
Brentuximab Biosimilar - Research Grade
$306.00 - $19,500.00
Osemitamab Biosimilar - Research Grade
Osemitamab Biosimilar - Research Grade
$306.00 - $19,500.00
Clazakizumab Biosimilar - Research Grade
Clazakizumab Biosimilar - Research Grade
$306.00 - $19,500.00
Bulk Anti-Human CD16 (3G8) Antibody
Bulk Anti-Human CD16 (3G8) Antibody
$390.00 - $2,885.00
Cemiplimab Biosimilar - Research Grade
Cemiplimab Biosimilar - Research Grade
$306.00 - $19,500.00
Bevacizumab Biosimilar - HRP Research Grade
Bevacizumab Biosimilar - HRP Research Grade
$357.00
Back to Top